The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May...
The IHMA says counterfeit cannabis is an alarming development that sees criminals taking advantage of people in desperate need of products.
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer's disease...
The partnership will help to accelerate and advance research for both cannabis and psychedelics.
The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief...
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials in humans.
It's been described as a "historic" moment for the sector.
The pilot study, which will be ran by Medicann, will collect data on various strains.